abstract |
The present invention provides a method of treating or preventing a condition selected from the group consisting of contact dermatitis, atopic dermatitis, drug-induced delayed skin allergic response, toxic epidermal necrosis, cutaneous T cell lymphoma, Acne vulgaris, nodular squamous, skin sclerosis, herpes simplex virus, or a combination thereof. Furthermore, the present invention provides hybridomas that generate monoclonal antibodies. |